Clinical trial
The Effect of Epoetin Alfa on Cardiac Function and Quality of Life in Patients…
NCT00446576 · Janssen-Cilag B.V., Industry · Completed
Key facts
| NCT number | NCT00446576 |
|---|---|
| Title | The Effect of Epoetin Alfa on Cardiac Function and Quality of Life in Patients With Early Renal ((Kidney) Disease |
| Official title | A Study in Early Renal Insufficiency Patients to Assess the Effect of Maintaining Three Different Hemoglobin Levels With the Use of Erythropoetin Alpha on Left Ventricular Hypertrophy and Dilation and Quality if Life; The "Cardiac Results of Early Treatment of Anaemia (CRETA)" Study |
| Lead sponsor | Janssen-Cilag B.V., Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Anemia |
| Intervention type | Drug |
| Interventions | Epoetin Alfa |
| Enrollment | 176 |
| Start date | Nov 1, 1999 |
| Completion | Apr 1, 2003 |
| First posted | Mar 13, 2007 |
| Last update posted | Feb 1, 2011 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: